SureTrader Nadex Advertisement SureTrader
Home > Boards > US OTC > Medical - Equipment >

Arrayit Corporation (ARYC)

Add ARYC Price Alert      Hide Sticky   Hide Intro
Moderator: lucky,mydog, Penny Traders Club, bz777, HighYieldStocks
Search This Board: 
Last Post: 4/25/2017 2:25:18 PM - Followers: 393 - Board type: Free - Posts Today: 61



Arrayit (ARYC) leads and empowers the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure.


- Powerful Science for Life™



Corporate Overview

Arrayit Corporation is a leading life sciences company providing innovative products and services to empower scientists and clinicians to explore the human genome as well as the genomes of plants and animals. Arrayit's worldwide business position leverages the company's widely used patented microarray manufacturing platform and revolutionary VIP™ genotyping technology. Nearly every major research center in the world uses Arrayit products including research laboratories, pharmaceutical companies, universities, biotechnology companies, hospitals, government agencies, and nonprofit research organizations. Novel insights into the function of genes and proteins, early stage disease diagnostics, better and safer medicines, and more nutritional crop plants are some of the many aspects of human health empowered by Arrayit technology.

Corporate Philosophy
Arrayit is an exciting and innovative public company that strives to increase shareholder equity by inventing, developing, manufacturing and supplying sophisticated life sciences products and services to an extensive customer base spanning 50 countries.
Our corporate philosophy is embodied by a highly skilled, multidisciplinary team of investors, business professionals, scientists, engineers and executive and support staff who place shareholder value, product quality, customer service and price competitiveness as our highest priorities. Arrayit empowers decisive strategic advantage and large return on investment for our customers in the research, pharmaceutical, diagnostic, and health care markets.

Corporate History
Arrayit Corporation was founded in 1993 by Rene' Schena and Todd Martinsky as TeleChem International, Inc, a chemical import and export company specializing in plastics, water soluble fertilizers, alternative fuels, and the life sciences. After several years of successful revenues growth, the company expanded in 1999 by adding Dr. Mark Schena and Paul Haje, who together with Ms. Schena and Mr. Martinsky, founded Arrayit Life Sciences, a division of TeleChem International, Inc. Arrayit sought to build on the opportunities created by the deciphering of the human genome and the rise of microarray technology. Arrayit microarrays are sophisticated glass substrates containing large collections of DNA and protein spots that allow all 25,000 human genes and every major protein in the human body to be analyzed in a few hours. Arrayit VIP™ microarrays enable the analysis of the DNA from 100,000 patients in one day. Since 1999, Arrayit has has build a powerful portfolio of patents, trade secrets, and more than 650 life sciences products. The company was featured on the television series
NOVA in 2001, received successive appointments to the Inc. 500 list in 2002 and 2003, and has received numerous local awards including the Rising Star award from the City of Sunnyvale and the Silicon Valley 50 award in 2003. The company changed its name to Arrayit Corporation and began trading on the OTC Bulletin Board in 2009 as ticker symbol ARYC. The company's products and services are used in the life sciences, pharmaceutical, and diagnostics markets, which are estimated at $690 billion in annual revenue.


OvaDx® Ovarian Cancer Diagnostic Test

In Development

Arrayit Diagnostics, Inc. provides the market's first large panel biomarker screening test for ovarian cancer. OvaDx® is a sophisticated microarray-based test that measures the activation of the immune system in blood samples in response to early stage ovarian tumor cell development. Research studies with OvaDx® indicate high sensitivity and specificity for all types and stages of ovarian cancer including stage IA-IV borderline serous, clear cell, endometrioid, mixed epithelial, mucinous, serous, and ovarian adenocarcinoma. Upon FDA approval, Arrayit Diagnostics will offer OvaDx® as an elective test for women seeking greater wellness and for women in the elevated risk category for ovarian cancer. OvaDx® will be used by doctors to advance the forefront of ovarian cancer treatment including improved surgical options, more effective chemotherapies, and to supplement existing tests including CA-125, OVA1®, and transvaginal ultrasound.


Diagnostics - Parkinson's Disease

Parkinsons Disease
Arrayit has leveraged the company's patented and proprietary microarray discovery platform to decipher the molecular basis of Parkinson's Disease (PD). This important research project, completed as a collaboration with The Parkinson's Institute (Sunnyvale, California), offers exciting promise for the pre-symptomatic and post-symptomatic diagnosis and treatment of this serious neurodegenerative condition. Arrayit is currently seeking a strategic partner to accelerate FDA approval of the Arrayit PDx™ Parkinson's Disagnostic Test, speed the benchmarking of PDx™ as a companion diagnostic, and determine and enhance the efficacy of pipeline therapeutic proteins and small molecules.


Avant Diagnostics, Inc.

Definitive diagnostic screening test for early stage detection


About Avant Diagnostics, Inc.


Avant Diagnostics, Inc., ("AD") previously named Arrayit Diagnostics, Inc., is a Nevada corporation presently a majority-owned subsidiary of Arrayit Corporation ("Arrayit"). AD's business is based upon the completion of the human genome sequencing project. Genetic research is increasingly focused on identifying the variations of the specific genes in the genome. These variations are what define individual characteristics, including disease states or a statistical propensity for disease. The implications are far-reaching and impact not only the research community, but also the individual patients and the medical providers. Diagnostic tests that detect diseases very early in their progression will provide options for earlier treatments that may improve the patient's quality of life and prognosis by delaying or preventing disease progression or even death. Medical providers will incur major cost savings by avoiding costly late stage disease treatments.


© 2013 by Avant Diagnostics, Inc., all rights reserved.

Related Articles



  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
ARYC News: Current Report Filing (8-k) 12/05/2016 04:31:06 PM
ARYC News: Current Report Filing (8-k) 12/05/2016 03:16:26 PM
#43578  Sticky Note SKULL AND CROSSBONES FOR ARYC. lucky,mydog 04/15/17 01:08:12 PM
#43132  Sticky Note I am here at arrayit office . ANRK 04/10/17 01:52:45 PM
#42929  Sticky Note ***Ten Reasons To Invest in Arrayit Corporation (ARYC)*** Penny Traders Club 04/01/17 11:54:57 AM
#41045  Sticky Note Here are the details and DD updates ChartAnalyst 02/08/17 10:32:34 AM
#45088   Oh I know it. THAT would make things techmover 04/25/17 02:34:52 PM
#45087   We really need to see financials soon Penny Traders Club 04/25/17 02:34:07 PM
#45086   Looks like this will be a slow move techmover 04/25/17 02:25:18 PM
#45085   nice ;-) Backstabbed 04/25/17 02:10:18 PM
#45084   Added more today havnagoodtime 04/25/17 01:50:39 PM
#45083   Short Term/Medium Term/Long Term with 100% Buy HighYieldStocks 04/25/17 01:46:39 PM
#45082 $$$$$$$$$$$$$$$$$$$$$ UndervaluedStocks 04/25/17 01:38:11 PM
#45081   Look at those prices, no wonder their daily UndervaluedStocks 04/25/17 01:37:05 PM
#45080   NEW...Arrayit new company newsletter features Arrayit Store for HighYieldStocks 04/25/17 01:29:07 PM
#45079   seems like and will be are two entirely Delsurfer 04/25/17 01:09:21 PM
#45078   ARYC - Arrayitt Corporation's tweet from march 2nd RyGuy 04/25/17 01:01:35 PM
#45077   Arrayit products and services in high demand...$$$$$ havnagoodtime 04/25/17 12:56:31 PM
#45076   Got it man just loaded some. kermel 04/25/17 12:34:47 PM
#45075   Slow and steady climb, no gaps. Welcome to UndervaluedStocks 04/25/17 12:32:09 PM
#45074   slow climb to .01 ill take it! mcaptrade 04/25/17 12:29:53 PM
#45073   NEW...Arrayit reports $29,000 microarray services sale to a HighYieldStocks 04/25/17 12:22:12 PM
#45072   NEW...Arrayit completes on-site microarray platform upgrade at world HighYieldStocks 04/25/17 12:21:47 PM
#45071   NEW...Arrayit reports microarray reagents sale to top biomedical HighYieldStocks 04/25/17 12:21:21 PM
#45070   Welcome to the ARYC board, Kermel. Great entry UndervaluedStocks 04/25/17 12:20:51 PM
#45069   It's Tuesday....Do you know where your financial reports are? Pencow 04/25/17 12:17:56 PM
#45068   techmover, just marked you @ 70 kermel 04/25/17 12:11:38 PM
#45067   What are projected Q1 numbers. seems like they JOHCOOP 04/25/17 12:10:58 PM
#45066   Agree- Q1 numbers will be great imo! bz777 04/25/17 12:08:11 PM
#45065   Every single trading day minimum sixish Twitter entries...weekly HighYieldStocks 04/25/17 11:47:32 AM
#45064   Solid action today - climbing good. bz777 04/25/17 11:46:57 AM
#45063   NEW...Arrayit reports microarray technology sale to top European HighYieldStocks 04/25/17 11:41:23 AM
#45062   NEW...Arrayit 260K twitter followers compare favorably with world's HighYieldStocks 04/25/17 11:35:39 AM
#45061   From the way things are looking seeing .01 techmover 04/25/17 11:29:25 AM
#45060   Maybe ARYC will see .01 before the 10K ?? UndervaluedStocks 04/25/17 11:25:04 AM
#45059   ARYC is up over 18% in the last week! Labradorite 04/25/17 10:51:15 AM
#45058   .0065/.0066 L2 is THIN to .007!! UndervaluedStocks 04/25/17 10:49:17 AM
#45057   I understand your concern. I think in general Labradorite 04/25/17 10:40:40 AM
#45056   L2 Showing some big orders Penny Traders Club 04/25/17 10:18:06 AM
#45055   L2 looking Clean Penny Traders Club 04/25/17 10:17:18 AM
#45054   Heavy volume so far this morning! Must be Labradorite 04/25/17 10:03:48 AM
#45053   All the past filings can be found here. MikeCr 04/25/17 09:44:13 AM
#45052   We'll see but it looks like churning the techmover 04/25/17 09:33:08 AM
#45051   L2 looks beautiful. :) UndervaluedStocks 04/25/17 09:32:56 AM
#45050   Churning the .006's today or gap to.007's??? UndervaluedStocks 04/25/17 09:22:55 AM
#45049   I would like to 2nd that! Good morning Meq 04/25/17 09:19:04 AM
#45048   Well said RyGuy! bz777 04/25/17 09:17:41 AM
#45047   ARYC is Extremely Undervalued trading at .0068. techmover 04/25/17 09:07:43 AM
#45046   It's called Speculative Investing. Speculation in OTC equities RyGuy 04/25/17 09:04:59 AM
#45045   Strange, the whole fuss has been they haven't techmover 04/25/17 08:45:50 AM
#45044   That was a good point...very good point! techmover 04/25/17 08:39:55 AM
#45043   Thank you for the information, I will have wssj 04/25/17 08:37:58 AM
#45042   the company is CURRENTLY non-reporting. lucky,mydog 04/25/17 08:37:07 AM
#45041   The ONLY thing that is holding back the UndervaluedStocks 04/25/17 08:35:15 AM
#45040   Well, it turns out, on the OTC, most mfdesigner 04/25/17 08:30:24 AM
#45039   Financial reports are coming either around April 30th techmover 04/25/17 08:29:00 AM